Voya Investment Management LLC Chemo Centryx, Inc. Transaction History

Voya Investment Management LLC

$79.9 Billion
Q3 2024

Shares

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	BUY	$22.17 - $51.8 $7,914 - $18,492	357 Added 1.49%	24,252 $1.25 Million
Q2 2022 Aug 15, 2022	BUY	$15.36 - $27.51 $45,726 - $81,897	2,977 Added 14.23%	23,895 $592,000
Q4 2021 Feb 14, 2022	BUY	$18.38 - $40.5 $5,017 - $11,056	273 Added 1.32%	20,918 $762,000
Q2 2021 Aug 16, 2021	SELL	$9.59 - $50.88 $11,862 - $62,938	-1,237 Reduced 5.65%	20,645 $276,000
Q1 2021 May 17, 2021	BUY	$49.53 - $68.4 $7,231 - $9,986	146 Added 0.67%	21,882 $1.12 Million
Q4 2020 Feb 16, 2021	BUY	$47.25 - $65.16 $244,566 - $337,268	5,176 Added 31.26%	21,736 $1.35 Million
Q3 2020 Nov 16, 2020	BUY	$46.35 - $61.69 $54,136 - $72,053	1,168 Added 7.59%	16,560 $907,000
Q2 2020 Aug 14, 2020	SELL	$38.58 - $65.07 $192,359 - $324,439	-4,986 Reduced 24.47%	15,392 $886,000
Q1 2020 May 15, 2020	BUY	$32.73 - $50.78 $13,190 - $20,464	403 Added 2.02%	20,378 $819,000
Q4 2019 Feb 14, 2020	BUY	$6.81 - $39.55 $35,949 - $208,784	5,279 Added 35.92%	19,975 $790,000
Q2 2019 Aug 14, 2019	BUY	$8.31 - $14.85 $34,137 - $61,003	4,108 Added 38.8%	14,696 $137,000
Q2 2018 Aug 14, 2018	SELL	$10.62 - $13.98 $18,022 - $23,724	-1,697 Reduced 13.81%	10,588 $139,000
Q1 2018 May 15, 2018	SELL	$5.9 - $14.99 $21,824 - $55,448	-3,699 Reduced 23.14%	12,285 $167,000
Q3 2017 Nov 14, 2017	BUY	$6.5 - $10.69 $103,896 - $170,868	15,984	15,984 $119,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.